統戰目標從擾亂疫情轉到拉抬罷免:
"在我這兩年的研究之中,一直在追蹤一種新型態的假新聞。這種假新聞出現在Youtube上,是由男性或女性的主播播報的。然而,這些主播很奇怪,會拿一個超大的麥克風把嘴巴跟臉遮住,然後動作不斷重複、而且講話語音是google翻譯小姐。而他們講話的內容,大多來自於《中國時報》、《周刊王》、或者是來自中國的內容農場。"
"這八個頻道在今年開始曾短暫提到陳柏惟,但大多時候並不討論他,或者每周只提到一次。而所有的頻道自從第39周開始,每周提到7次以上陳柏惟,而在本周第40周,更是每周提到15次陳柏惟以上,而本周尚未結束"
中國已有大型運補無人機支援南海的能力:
“The Chinese navy’s South Sea Fleet publicized the maneuver—which used three airstrips on artificial islands that China built atop small reefs in recent years—on an official social-media account last week.
The navy’s disclosure of the mission marks China’s first known public acknowledgment that the bases on the islands have been used to accommodate large aircraft. Last December, satellite images appeared to show one of China’s newly developed Y-20 aircraft on an airstrip at Fiery Cross, which is one of the airstrips used last week. The authenticity of the images, shared online by Ken Joyce, director of product management at the U.S.-based imaging firm Maxar Technologies, hasn’t been confirmed by Chinese officials.”
“高盛證券出報告,中國地方政府融資平台(LGFV)債務總額已由2013年的16兆元增至2020年底的53兆元人民幣,這個金額相當於中國國內生產毛額(GDP)的52%,遠高於官方公布的中國政府尚未清償債務總額。2021年中國各省市預定發債3.65兆元人民幣,2022年可能還要擴大發債。
不論是國企,還是中國地方政府,靠的都是銀行裡面融通的信貸,而信貸正逐漸喪失刺激中國經濟發展的能力。中國《證券時報》旗下的「資料寶」和騰訊財經於10月5日發布「城市債務率排名」,90%的中國城市在技術上已經破產。”
“地方政府收入急遽下降的情況蔓延,反映在金融市場上就是地方政府發行的債券違約可能性大增;前面提過高盛證券的估算,恒大倒下所留下的爛帳「只有」兩兆元人民幣,如果地方政府大部分的債務違約,銀行貸款加上地方政府債券,約53兆元人民幣,這才是真正的金融核彈。”
AUKUS後續發酵:
“美菲將恢復全面軍演,並邀英澳為觀察員一事,正好在美英澳九月組成「澳英美三方安全夥伴(AUKUS)」,協助澳方取得核動力潛艦後。”
“沃梅斯警告,美國需要準備應對中俄對美國本土的直接攻擊。
她說:「未來,如果威懾失效,如果中俄犯下以軍事侵略威脅美國切身利益的戰略錯誤,我們就不能再指望有幾個月的時間,從一個不存在爭端的本土向海外投射戰鬥力,也不能指望迅速建立空中優勢,我們甚至可能面臨針對美國自身的攻擊。」”
「評審團表示,初安民擔任印刻總編輯近20年,堅持經營本土文學,不僅出版名家作品、栽培新銳作家,所出版著作獲獎無數;留下許多珍貴文學史料,並致力於文學推廣,辦理文學營、文學獎,持續為台灣堅守一座文學莊園,精神可佩、成就非凡。」
看《四樓的天堂》時對台詞水準跟不上題材和實力派演員形成不協調落差的這點就很有感。
順便抱怨:重劃區迫遷的戲碼雖然很跟得上時事,但生硬感跟小綠的演技一樣,對台劇這種硬塞明顯預設道德立場的老毛病真的很感冒。😩
"劇本開發的業界流程,通常分為5個階段:田野調查、故事大綱、分集大綱、分場大綱、對白本(即大眾俗稱的劇本),以10集、每集60分鐘的影集來說,這段路程最快也得花上13到14個月時間。
其中最為關鍵的,莫過於田調階段。這個階段是編劇透過閱讀資料、訪問等過程,跟導演、製作人討論出可以拍攝的類型、預算和時間規格,至少要花3到6個月,接著才會花5至6個月寫各階段大綱,實際的對白本則大概要花2個月上下,因此綜合來看,整個編劇流程有8成時間,是花費在寫劇本之前的開發工作。"
東協兩巨頭微妙的立場差異:
[ Shortly after the announcement of AUKUS, Indonesia said that it was “deeply concerned about the continuing arms race and power projection in the region.” Meanwhile, Malaysia’s Prime Minister Ismail Sabri Yaakob, said that the AUKUS pact could “provoke other powers to take more aggressive action in this region, especially in the South China Sea.” He added that it could be a “catalyst for a nuclear arms race in the Indo-Pacific region.” ]
https://thediplomat.com/2021/10/malaysian-defense-minister-hoping-for-asean-consensus-on-aukus/
"Asia’s pharmaceutical growth spurt comes at an opportune time, as deeper structural shifts in the global drug market undermine the West’s traditional edge. Over the last 10 years, patents have begun to expire on some of big pharma’s most profitable drugs, sapping revenue needed to produce and maintain profits from high-value products. Meanwhile, there has been an enormous growth in emerging markets where cheaper generic drugs are in high demand. These trends are forcing the West’s pharmaceutical giants to diversify toward generic production, where they lack the advantage of IP protections. Now they must compete with well-established generics manufacturers in countries like India and Thailand who are free to produce and sell their own versions of newly “off-patent” drugs at a fraction of the price. Asia’s pharmaceutical companies are in a favorable position to compete in the increasingly lucrative generics market while expanding into higher-value products on the back of the pandemic as big pharma’s portfolio of these products shrinks."
這篇點出東協想在美中競合賽局裡分一杯羹, 但在印太軍備競賽升溫的前提下, 不站隊者其實要承擔的是池魚風險:
"ASEAN can help to distribute public goods in a more effective manner through close consultation and coordination, either bilaterally, multilaterally with ASEAN as a whole, or minilaterally with ASEAN member states. In this way, ASEAN and the Indo-Pacific as a whole can proactively retain their voice in great power competition, playing a role in facilitating cooperation and mitigating conflicts for the interests of everyone involved."
https://thediplomat.com/2021/10/the-shift-in-china-us-competition/
中國在撒哈拉以南的非洲深耕規模驚人:
"In recent times, the African trade landscape has seen a large and monumental shift from colonial trade routes to majority trade with China. China is now sub-Saharan Africa’s most visible and biggest trade partner.
Since the early 2000s, China’s trade with Africa has increased by over 2,000 percent, reaching $200 billion in 2019. China has since announced its $1 billion Belt and Road Africa infrastructure development fund to help build roads and necessary infrastructure to aid trade on the continent. But the African continent has also seen a change in its business landscape. As of 2017, there were reportedly over 10,000 Chinese-owned firms operating across the continent. These Chinese businesses are valued at over $2 trillion."
https://thediplomat.com/2021/10/why-is-china-looking-to-establish-banks-in-nigeria/
"根據《讀賣新聞》 報導,指出mRNA疫苗注射進人體後,會因免疫反應引起發炎,導致mRNA難以應用在疫苗上。對此,現任德國BioNTech製藥高級副總裁、研究mRNA技術的匈牙利裔美籍生技科學家考里科(Katalin Kariko),便想到將構成mRNA的其中一個物質「脲苷」(Uridine)換成「假脲苷」,讓人體的免疫系統不會將mRNA判定為「入侵種」,實驗也獲得成功。
而製作醬油將近400年、總公司位於千葉縣銚子市的山佐醬油,過去為製造出醬油的鮮味成分,1970年就開始跨足製藥領域並投入研究。據悉該公司從1980年代起向海外輸出假脲苷。雖然過去假脲苷僅用於學術研究,輸出量很少,但因為疫情的關係,讓假脲苷需求量大增,輸出量暴增到數10倍以上。"
2024/02/29停用。